128 related articles for article (PubMed ID: 38764828)
21. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei.
Liang L; Fang J; Han X; Zhai X; Song Y; Lu Y; Zhang Q; Ma R
Front Oncol; 2021; 11():594763. PubMed ID: 34733775
[TBL] [Abstract][Full Text] [Related]
22. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.
Peng Y; Zhai Z; Li Z; Wang L; Gu J
Int J Clin Exp Med; 2015; 8(1):982-90. PubMed ID: 25785084
[TBL] [Abstract][Full Text] [Related]
23. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
24. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
[TBL] [Abstract][Full Text] [Related]
25. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
Rao H; Wu H; Huang Q; Yu Z; Zhong Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
[TBL] [Abstract][Full Text] [Related]
26. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
Yang XQ; Chen C; Peng CW; Liu SP; Li Y
Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
[TBL] [Abstract][Full Text] [Related]
27. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.
Jiang JT; Wu CP; Deng HF; Lu MY; Wu J; Zhang HY; Sun WH; Ji M
World J Gastroenterol; 2004 Jun; 10(11):1675-7. PubMed ID: 15162550
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma.
Zhao H; Lu B
Cancer Manag Res; 2022; 14():249-255. PubMed ID: 35082529
[TBL] [Abstract][Full Text] [Related]
30. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.
Liang H; Yang X
J Oncol; 2022; 2022():7742760. PubMed ID: 36245974
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer.
Hu C; Zhang Y; Xu J; Chen W; Yu P; Wang Y; Bao Z; Zhang R; Xu Z; Cheng X
Ann Transl Med; 2022 Feb; 10(3):153. PubMed ID: 35284544
[TBL] [Abstract][Full Text] [Related]
33. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
34. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
[TBL] [Abstract][Full Text] [Related]
36. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
38. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients.
Kuang J; Gong Y; Xie H; Yan L; Huang S; Gao F; Tang S; Gan J
PeerJ; 2020; 8():e8936. PubMed ID: 32328348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]